The largest database of trusted experimental protocols

5 protocols using erlotinib osi 744

1

Cell Viability Assay for Inhibitor Screening

Check if the same lab product or an alternative is used in the 5 most similar protocols
For proliferation assays cells were plated in 384-well plates at a density of 800 cells per well in 40 µl total volume. One day later, a serial dilution of each inhibitor was performed using a D300e dispenser (Tecan). 96 h post-treatment, cell viability was determined using CellTiterGlo reagent (Promega) and luminescence quantified on an Envision MultiLabel Plate Reader (PerkinElmer). To calculate the fraction cell viability drug-treated cells were normalized to average cell viability of DMSO-only treated cells. Curve fitting was performed using GraphPad Prism v9.1.1 four-parameter inhibitor response with variable slope. AUC values were calculated by GraphPad Prism v9.1.1. Inhibitors were obtained from SelleckChem: Erlotinib-OSI-744 (S1023), Osimertinib-AZD9291 (S7297), Torin 1 (S2827), Alisertib-MLN8237 (S1133), Barasertib-AZD1152 (S1147). DMSO (Sigma-Aldrich).
+ Open protocol
+ Expand
2

Small Molecule Inhibitors in Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Afatinib (BIBW2992) and erlotinib (OSI-744) were purchased from Selleck Chemicals (TX, USA). The protein assay kit was from Bio-Rad (Hercules, CA, USA). The E-cadherin antibody was a gift from Dr. Keith R. Johnson (University of Nebraska Medical Center). All other antibodies used are listed in Supplementary Table 1.
+ Open protocol
+ Expand
3

Developing Erlotinib-Resistant Lung Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human lung cancer HCC827 cell line was purchased from ATCC (ATCC® CRL-2868™). The PC9 cell line, which was derived from a human adenocarcinoma of lung tissue, was preserved in our laboratory. The lung cancer cells were cultured in RPMI-1640 medium containing 10% fetal bovine serum (Gibco BRL, Carlsbad, CA, USA) and 100 U/ml penicillin/streptomycin at 37°C in a humidified incubator containing 5% CO2. Erlotinib (OSI-744) was purchased from Selleck Chemicals (Houston, TX, USA). Insulin-like growth factor 1 human recombinant was obtained from ProSpec (ProSpec, Rehovot, Israel). Two erlotinib-resistant lines, namely HCC827/ER and PC9/ER, were developed by applying high-dose (1–5 μM) pulses of erlotinib combined with continuous low-dose (0.01 μM) administration for >8 months (13 (link)). To avoid the effects of the drugs, resistant cell lines were cultured in a drug-free medium for ≥2 weeks prior to further experiments.
+ Open protocol
+ Expand
4

Proliferation Assay with Kinase Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
For proliferation assays cells were plated in 384-well plates at a density of 800 cells per well in 40 µl total volume. One day later, a serial dilution of each inhibitor was performed using a D300e dispenser (Tecan). 96 hours post-treatment, cell viability was determined using CellTiterGlo reagent (Promega) and luminescence quantified on an Envision MultiLabel Plate Reader (PerkinElmer). To calculate the fraction cell viability drug-treated cells were normalized to average cell viability of DMSO-only treated cells. Curve fitting was performed using GraphPad Prism four parameter inhibitor response with variable slope. AUC values were calculated by GraphPad Prism (Graphpad). Inhibitors were obtained from SelleckChem: Erlotinib-OSI-744 (S1023), Osimertinib-AZD9291 (S7297), Torin 1 (S2827), Alisertib-MLN8237 (S1133), Barasertib-AZD1152 (S1147). DMSO (Sigma-Aldrich).
+ Open protocol
+ Expand
5

Establishment of Erlotinib-Resistant Lung Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human lung cancer HCC827 cell line was purchased from ATCC (ATCC ® CRL-2868™). HCC827/ER cells were cultured by Dr Jing Han by applying high-dose (1-5 µM) pulses of erlotinib combined with continuous lowdose (0.01 µM) administration for >8 months (12). H1650/ ER cells were presented by Dr Li Li (Department of Respiratory Disease, Daping Hospital, Third Military Medical University, Chongqing, China). The lung cancer cells were grown in RPMI-1640 medium containing 10% fetal bovine serum (Gibco BRL, Carlsbad, CA, USA) and 100 U/mL penicillin/streptomycin at 37°C in a humidified incubator containing 5% CO 2 . Erlotinib (OSI-744) was purchased from Selleck Chemicals (Houston, TX, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!